Atomoxetine Hydrochloride/Trazodone Hydrochloride
- Generic Name
- Atomoxetine Hydrochloride/Trazodone Hydrochloride
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Phase 2
Completed
- Conditions
- OSA - Obstructive Sleep Apnea
- Interventions
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2022-12-12
- Lead Sponsor
- Apnimed
- Target Recruit Count
- 294
- Registration Number
- NCT05071612
- Locations
- 🇺🇸
Velocity Clinical Research, Greenville, South Carolina, United States
🇺🇸The Center for Sleep & Wake Disorders, Chevy Chase, Maryland, United States
🇺🇸NeuroTrials Research, Inc., Atlanta, Georgia, United States
Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
Phase 2
Completed
- Conditions
- Obstructive Sleep Apnea
- Interventions
- First Posted Date
- 2020-11-27
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Apnimed
- Target Recruit Count
- 15
- Registration Number
- NCT04645524
- Locations
- 🇺🇸
Intrepid research, LLC, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath